Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
12/2005
12/15/2005WO2005117577A2 Model for neurodegenerative disorders
12/15/2005WO2005117562A2 Ent1 transporters expressed in cancer cells
12/15/2005WO2005117556A2 Quantitative lateral flow system and assay
12/15/2005WO2005117532A2 Method for improved breast milk feeding to reduce the risk of allergy
12/15/2005WO2005108597A3 Process for high throughput liquid or gas chromatography/mass spectrometry-based biomolecular screening for drug discovery
12/15/2005WO2005106491A3 Diagnostics and therapeutics for diseases associated with serum/glucocorticoid regulated kinase 1 (sgk1)
12/15/2005WO2005106012A3 Diagnostics and therapeutics for diseases associated with dipeptidyl-peptidase 1 (dpp1)
12/15/2005WO2005103719A3 Using plasma proteomic pattern for diagnosis, classification, prediction of response to therapy and clinical behavior, stratification of therapy, and monitoring disease in hematologic malignancies
12/15/2005WO2005103263B1 Bone delivery conjugates and method of using same to target proteins to bone
12/15/2005WO2005100589A3 Kinetic process for the detection, diagnosis, processing, and monitoring of clonal cell populations
12/15/2005WO2005098442A3 Assay system and method for direct measurement of ldl cholesterol
12/15/2005WO2005098438B1 Analysis array comprising heatable electrodes, and methods for chemical and biochemical analysis
12/15/2005WO2005098430A3 Image based quantitation of molecular translocation
12/15/2005WO2005086713A3 Role of human endothelial precursor cells and vascular pericytes tumor in angiogenesis
12/15/2005WO2005083126A3 Alterations of fibulin genes in macular degeneration
12/15/2005WO2005080985A3 Methods and compositions for detecting and treating autoimmune diseases
12/15/2005WO2005080430A8 Anti-ube4a/ufd2b polyclonal antibody and its use thereof as diagnostic and prognostic marker of 11q23 region alterations
12/15/2005WO2005075666A3 Diagnostics and therapeutics for diseases associated with puromycin sensitive aminopeptidase npepps (npepps)
12/15/2005WO2005067425A3 Bacterial biosensors
12/15/2005WO2005065411A3 Test apparatus for direct measurement of expansion and shrinkage of oil well cements
12/15/2005WO2005063976A3 Methods for inducing differentiation of undifferentiated mammalian cells into osteoblasts
12/15/2005WO2005062049A3 The use of microelectronic structures for patterned deposition of molecules onto surfaces
12/15/2005WO2005051423A3 Methods and agents for immune modulation and methods for identifying immune modulators
12/15/2005WO2005047854A3 Fiber-optic assay apparatus based on phase-shift interferometry
12/15/2005WO2005045075A3 Sample preparation methods and devices
12/15/2005WO2005044091A3 Diagnostic and therapeutic methods and compositions involving pten and breast cancer
12/15/2005WO2005040755A3 Nanoscale transduction systems for detecting molecular interactions
12/15/2005WO2005034735A3 Method for assessing the risk for insulin resistant diabetes and/or heart disease
12/15/2005WO2005033267A3 Antigens targeted by prevalent pathogenic t cells in type 1 diabetes and uses thereof
12/15/2005WO2005032328A3 Compositions, kits, and methods for identification, assessment, prevention, and therapy of rheumatoid arthritis
12/15/2005WO2005029037A3 Selective modulation of tlr gene expression
12/15/2005WO2005024695A8 Methods for encoding non-biological information on microarrays
12/15/2005WO2004105573A3 Method of diagnosis of cancer based on gene expression profiles in cells
12/15/2005WO2004101130A3 System, method, and product for providing a wavelength-tunable excitation beam
12/15/2005WO2004096989A9 Single chain antigen-binding polypeptides for polymer conjugation
12/15/2005WO2004091526A3 Keratin 8 and 18 mutations are risk factors for developing liver disease of multiple etiologies
12/15/2005WO2004091507A3 Optimal polyvalent vaccine for cancer
12/15/2005WO2004079337A3 Voltage sensor domains of voltage-dependent ion channel proteins and uses thereof
12/15/2005WO2004070344A3 Method of screening for agents which modulate the activity of tlr9
12/15/2005WO2004047757A3 Diagnosing and treating hematopoietic cancers
12/15/2005WO2004041842A3 Epitopes of hepatitis c virus
12/15/2005WO2004034022A3 Shape optimization to solve inverse problems and curve/model fitting problems
12/15/2005WO2004029072A3 PrPsc -INTERACTING MOLECULES AND USES THEREOF
12/15/2005WO2004012588A3 Use of biomarkers for detecting ovarian cancer
12/15/2005WO2004007754A3 Modulators of cellular proliferation
12/15/2005WO2004000102A3 Method for predicting response to epidermal growth factor receptor-directed therapy
12/15/2005WO2003063759A3 Hsp peptides and analogs for modulation of immune responses via antigen presenting cells
12/15/2005WO2003061586A3 High affinity sensor for biological pathogens
12/15/2005WO2003029409A3 Methods for generating, selecting, and identifying compounds which bind a target molecule
12/15/2005WO2002083921A8 Nuleic acids and corresponding proteins useful in the detection and treatment of various cancers
12/15/2005WO2002083855A3 Novel streptococcus pneumoniae open reading frames encoding polypeptide antigens and uses thereof
12/15/2005US20050278125 V-life matching and mating system
12/15/2005US20050278124 Methods for molecular property modeling using virtual data
12/15/2005US20050277710 Tagged resin, method of making a tagged resin, and articles made therefrom
12/15/2005US20050277618 Methods
12/15/2005US20050277612 Methods, compositions and compound assays for inhibiting amyloid-beta protein production
12/15/2005US20050277606 Administering by direct injection into heart an expression vector comprising a nucleic acid sequence encoding AOP-1 operably linked to a promoter, wherein expression of nucleic acid sequence within cells of heart enhances production of AOP-1, protecting against myocardial cell death
12/15/2005US20050277205 Multicomponent magnetic nanorods for biomolecular separations
12/15/2005US20050277204 Sample preparation methods and devices
12/15/2005US20050277203 Immunochemical filter device and methods for use thereof
12/15/2005US20050277202 Collection member is separated from the remainder of the chromatography strip by a liquid impermeable removable barrier which prevents liquid in the collection member from entering the chromatography strip; avoids reflux of reagents from the strip into the mouth; simple and convenient assay; home use
12/15/2005US20050277201 Contacting polypeptides or proteins with mat of tubes by placing solvent solution on it; evaporation
12/15/2005US20050277197 Microparticles with multiple fluorescent signals and methods of using same
12/15/2005US20050277186 Imaging system for examining biological material
12/15/2005US20050277181 for increasing or decreasing binding of lysozyme polypeptide to Treponema pallidum P17 polypeptide (Tp17); immunoassay, ELISA
12/15/2005US20050277173 inoculating human lymphocytes, mitogens or polyclonal activators, to cultures and control cultures, then determining the degree of apoptosis and proliferation in the cultures; design of synthetic immunogens; screening of ligands that yield pharmacological effects
12/15/2005US20050277168 Apparatus and methods for scanning and producing biological specimen film strips
12/15/2005US20050277166 Method for measuring polyamines in erythrocytes, diagnostic method and kit for measuring polyamines in erythrocytes
12/15/2005US20050277165 Novel treatment
12/15/2005US20050277164 Blood glucose tracking apparatus and methods
12/15/2005US20050277163 Determining presence or absence of the antigen in the sample by a signal formed by the binding of the antigen-indicator labeling reagent complex to an indicator capture reagent specific for antigen-indicator labeling reagent complex
12/15/2005US20050277162 Detection and modulation of cancer stem cells
12/15/2005US20050277161 Phosphopeptide antigens associated with MHC molecules
12/15/2005US20050277159 Measuring secreted soluble cell products using nanoparticles and/or microparticles with associated capture reagents that recognize the cellular product; improved reliability and accuracy
12/15/2005US20050277158 Method and kit for donor specific complement-fixing antibodies crossmatch
12/15/2005US20050277156 Useful as diagnostic markers for cardiac diseases and/or pathology
12/15/2005US20050277155 Method of immobilizing probes, in particular for producing biochips
12/15/2005US20050277154 Combinatorial complex carbohydrate libraries and methods for the manufacture and uses thereof
12/15/2005US20050277149 Pharmaceutically tractable secondary drug targets, methods of identification and their use in the creation of small molecule therapeutics
12/15/2005US20050277148 Method for preparing correlation diagram or multiple alignment among nucleic acid sequences and program thereof
12/15/2005US20050277144 Compounds and methods for fluorescent labeling
12/15/2005US20050277143 Formed by fusing a pinanediol bound to a solid support with a boronic or boric acid bound to a biomolecule; an array may be constructed by preparing the conjugate at a plurality of spatially distinct reaction sites on the solid support
12/15/2005US20050277142 Recombinant cell line for the detection of dioxin-like compounds based on the expression of luciferase gene
12/15/2005US20050277140 diagnosing non-inflammatory chronic pelvic pain syndrome in a male subject by detecting Monocyte chemoattractant protein-1 (MCP-1) and Macrophage Inflammatory Proteins (MIP)
12/15/2005US20050277137 Diagnosing pancreatic cell proliferative disorders via concentration of tumor marker antigen in blood; immunoassay
12/15/2005US20050277132 Nematode GS-like sequences
12/15/2005US20050277131 Mass spectrometry-based identification of proteins
12/15/2005US20050277130 Removing aurintricarboxylic acid (ATA), a reverse transcriptase inhibitor, from a blood sample containing ATA and a chaotropic salt for nucleic acid extraction by using urea at a pH of about 8.0; high speed analysis by creating a fibrin aggregate to confine pathogens to facilitate pathogen DNA extraction
12/15/2005US20050277128 Using magnetic particles comprising immobilized messenger RNA sequences to generate sublibraries of preferential gene sequences
12/15/2005US20050277126 Cytokine receptor chain
12/15/2005US20050277119 Substituted azaporphyrins as fluorescence labels
12/15/2005US20050277117 Drug discovery method
12/15/2005US20050277116 Compositions and methods for the identification of protein interactions in vertebrate cells
12/15/2005US20050277113 Saliva immunoassay for detection of exposure to infectious agents
12/15/2005US20050277110 Method of measuring the activity of G(alpha)i- or G(alpha)o-coupled receptors using Ca2+ influx in cells
12/15/2005US20050277109 Predictive assay for immune response
12/15/2005US20050276907 determine the evenness of the paint or coatings on the cover surfaces
12/15/2005US20050276901 Assay and method for quantifying the levels of steryl esters and free sterols in starch-containing food products
12/15/2005US20050276863 Methods for treatment of aneurysmal tissue
12/15/2005US20050276821 Antigen protein and nucleic acid coding for said protein
1 ... 1977 1978 1979 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 ... 3937